# SEG External Evidence Collection Report v1

**Mode:** `CONTROLLED GOVERNANCE EXECUTION`  
**Scope:** Evidence collection and recording only; no source approval, normalization, import, activation, publication, or production integration.  
**Prepared by:** **Manus AI**  
**Final status:** `SEG_EXTERNAL_EVIDENCE_COLLECTION_BATCH_COMPLETE`

## 1. Purpose and Control Boundary

This report records evidence that was already available in the SEG project workspace and source-governance reports. It does not treat a filename, checksum, archive inventory, structural count, recovered representation, or reviewer requirement as proof of source identity, rights, provenance, medical correctness, technical safety, or approval. No new authoritative external source artifact was supplied or independently verified in this batch; therefore, the results below are evidence-status updates for the acquisition queue, not source-level closure decisions.

The eight content-source tracks remain separate from the JEM Nexus Calculator tool track. No source has been approved, no evidence gate has been closed, and no Source Registry approval state has been changed.

## 2. Official Governance State

| Control | Current state |
|---|---|
| Documentation governance | `SEG_GOVERNANCE_DOCUMENTATION_REVISION_COMPLETE` |
| Approved sources | `APPROVED_SOURCES = NONE` |
| Normalization | `BLOCKED_PENDING_APPROVED_SOURCE` |
| Source-level gates | Open unless individually approved through the governed evidence and review process |
| Registry mutation | Not performed by this report |
| Production integration | Not authorized |

## 3. Collected Evidence and Current Classification

The classifications below describe what the current project evidence can support. They do not represent approval.

| Source | Existing project evidence recorded | Identity | Provenance | Rights | Medical review | Technical review | Current gate |
|---|---|---|---|---|---|---|---|
| Drug HTML | Recovered static HTML artifact, checksum and structural/entity observations recorded in the recovery and closure reports | `PARTIALLY_CONFIRMED` | `PARTIALLY_CONFIRMED` | `NOT_AVAILABLE` | `PENDING` | `PENDING` for representation review | `BLOCKED_PENDING_EVIDENCE` |
| OSCE Atlas | Recovered ZIP/container, text artifact, validation notes, and 14 PNG members with recorded inventory/hash evidence | `PARTIALLY_CONFIRMED` | `PARTIALLY_CONFIRMED` | `NOT_AVAILABLE` | `PENDING` | `PENDING` | `BLOCKED_PENDING_EVIDENCE` |
| PreTest | Recovered text representation, checksum/lineage observations, OCR and authoritative-PDF gap recorded | `PARTIALLY_CONFIRMED` | `PARTIALLY_CONFIRMED` | `NOT_AVAILABLE` | `PENDING` | `PENDING` | `BLOCKED_PENDING_EVIDENCE` |
| HIPPO HY | Text, colored PDF, and DOCX representations with checksum-verifiable retained artifacts | `PARTIALLY_CONFIRMED` | `PARTIALLY_CONFIRMED` | `NOT_AVAILABLE` | `PENDING` | `PENDING` | `BLOCKED_PENDING_EVIDENCE` |
| HIPPO QBank | Registered QBank text, structural observations, path/checksum continuity, and recovery notes | `PARTIALLY_CONFIRMED` | `PARTIALLY_CONFIRMED` | `NOT_AVAILABLE` | `PENDING` | `PENDING` | `BLOCKED_PENDING_EVIDENCE` |
| FRCEM | Five retained representations, checksum/path evidence, duplicate relationship, and representation notes | `PARTIALLY_CONFIRMED` | `PARTIALLY_CONFIRMED` | `NOT_AVAILABLE` | `PENDING` | `PENDING` | `BLOCKED_PENDING_EVIDENCE` |
| Clinical Images | No standalone source-specific package, authoritative locator, or per-file source manifest is currently available | `NOT_AVAILABLE` | `NOT_AVAILABLE` | `NOT_AVAILABLE` | `PENDING` | `PENDING` | `BLOCKED_PENDING_EVIDENCE` |
| Hamilton Ventilator Clinical Engineering Guide | ZIP and embedded PDF integrity/hash evidence; mixed PDF/application candidate documented | `PARTIALLY_CONFIRMED` | `PARTIALLY_CONFIRMED` | `NOT_AVAILABLE` | `PENDING` | `PENDING` | `BLOCKED_PENDING_EVIDENCE` |
| JEM Nexus Calculator — separate tool track | Static artifact inventory and supplied package continuity are recorded; no owner-controlled release evidence | `PARTIALLY_CONFIRMED` | `PARTIALLY_CONFIRMED` | `NOT_AVAILABLE` | `PENDING` | `PENDING` | `BLOCKED_PENDING_EVIDENCE` |

### 3.1 Interpretation of the Review State

`PENDING` means that the relevant review is required or queued but has not produced a completed, attributable decision for the exact retained representation. It is not an approval. No row above has `CONFIRMED` rights, and no row has a completed medical or technical review.

## 4. Source-by-Source Evidence Record

### 4.1 Drug HTML

The available evidence establishes continuity of a retained HTML artifact and records structural observations. It does not establish the canonical publication title, responsible publisher or owner, authoritative version/date, original locator, redistribution permission, or a complete original-to-extraction chain. The exact artifact still requires Emergency Medicine medication/pharmacology review, including disposition of dose, interaction, contraindication, and ambiguity conflicts. The next allowed step is to obtain attributable identity, rights, and provenance evidence and then queue exact-artifact review while preserving the HTML unchanged.

### 4.2 OSCE Atlas

The available evidence establishes a recovered package, associated text, validation notes, and 14 PNG members. It does not establish the authoritative atlas source, publisher/owner, version/date, per-image ownership, image-to-source locators, or redistribution rights. Clinical OSCE review, visual-quality review, accessibility review, completeness reconciliation, provenance review, and technical package review remain pending. The OSCE images must not be substituted for a different Clinical Images source family.

### 4.3 PreTest

The available evidence establishes a recovered representation and checksum/lineage observations, while also recording the absence of the authoritative `pretestnew.pdf` or independently verifiable equivalent and known OCR/representation gaps. Identity, rights, authoritative provenance, completeness/numbering, and assessment review remain open. The recovered text must be preserved without silent correction while authoritative comparison and qualified PreTest assessment review are requested.

### 4.4 HIPPO High Yield

The available evidence consists of retained text, colored PDF, and DOCX representations with checksum continuity. It does not confirm the canonical source identity, owner, edition/version/date, representation-specific rights, original locator, or extraction event. Exact-representation clinical review, track evidence, locators, completeness, and conflict disposition remain open. The representations must remain separate and internal.

### 4.5 HIPPO QBank

The available evidence establishes a registered QBank representation and structural observations only. Official identity/version, authoritative release and completeness, stable question locators, rights, provenance, professional-track evidence, and question-level medical review are missing. Structural counts are not evidence of completeness or correctness. The next allowed action is to obtain an official release/evidence packet and queue question-level and track review.

### 4.6 FRCEM Representations

The available evidence establishes five retained representations, their recorded paths/checksums, and duplicate/representation relationships. It does not establish canonical authority, official edition/version/date, text/PDF/DOCX rights, authoritative locators, or the complete original-to-extraction chain. Study-book and Q&A representations require separate medical review and track decisions. No merge or normalization is permitted.

### 4.7 Clinical Images

The current project evidence does not establish a standalone Clinical Images source family, source package, authoritative locator, per-file inventory, or source-to-artifact lineage. Rights, image interpretation, visual quality, accessibility/alt text, completeness, and track evidence are therefore unavailable or pending. The next allowed action is source-specific recovery or independent location followed by an evidence-only per-file inventory; OSCE PNGs must not be used as a substitute.

### 4.8 Hamilton Ventilator Clinical Engineering Guide

The available evidence establishes local archive and embedded-PDF integrity/hash observations and identifies a mixed PDF/application candidate. It does not close the original locator, owner, edition/version/date, device/configuration/software relationship, transformation history, or rights for PDF/text/translation/visuals/code/dependencies. Emergency Medicine/ICU and ventilation review, biomedical/device technical review, currency verification, track/taxonomy review, and audit closure remain pending. The candidate remains internal and blocked.

### 4.9 JEM Nexus Calculator — Separate Tool Track

The available evidence establishes a supplied static artifact inventory and continuity of the submitted package. It does not establish the original developer/owner, repository or release locator, immutable version/commit, documentation, formula-by-function validation, clinical references, license, dependency rights, privacy/PHI handling, external AI data flow, reproducible tests, security findings, or intended users. JEM remains outside the eight-source registry and must not be executed, called, integrated, mapped, normalized, imported, or exposed.

## 5. Evidence Closure Priority Queue

The queue preserves the existing SEG priority structure and uses evidence availability, clinical value, review complexity, and dependency impact as the ordering rationale. A priority is not an approval.

| Priority | Source(s) | Rationale | Immediate evidence objective |
|---|---|---|---|
| `P0` | Drug HTML | High dependency on medication/pharmacology safety and identity/rights closure; retained artifact exists but authoritative source evidence is missing | Obtain owner/version/locator, rights, provenance, and exact-artifact Emergency Medicine medication review |
| `P0` | OSCE Atlas | Clinical and visual educational value with 14 image assets; per-image rights, locators, and accessibility create high closure complexity | Obtain authoritative atlas/owner evidence, text/image rights, per-image lineage, and OSCE/visual/accessibility review |
| `P0` | PreTest | Assessment content has direct clinical and educational impact; authoritative-PDF and OCR/completeness dependency remains unresolved | Obtain authoritative representation, immutable comparison, rights/provenance, completeness, and assessment review |
| `P1` | HIPPO HY | Multiple retained representations require identity, representation-specific rights, track, and exact-form review | Close source/version, rights/provenance, track, and exact-representation review |
| `P1` | HIPPO QBank | Question-level completeness, stable locators, rights, and clinical review are high-effort dependencies | Obtain official release/completeness evidence and queue question-level review |
| `P1` | FRCEM | Multiple representations and separate study-book/Q&A review increase reconciliation complexity | Close authority/version, rights/locators/provenance, and separate review queues |
| `P1` | Clinical Images | No standalone artifact is available; this is a foundational acquisition blocker before any image review | Recover a source-specific package and create per-file evidence inventory |
| `Targeted closure — content candidate` | Hamilton Ventilator Guide | Mixed PDF/application candidate requires both clinical/device-technical evidence and transformation/rights closure | Obtain owner-issued identity/rights/configuration packet and role-based medical/device review |
| `Separate tool governance queue` | JEM Nexus Calculator | Tool execution, software/security, clinical formula, privacy, and license evidence are unresolved; it is not a content-source normalization candidate | Obtain developer/release, clinical validation, license, security/privacy, and reproducibility evidence without executing or integrating the tool |

## 6. Evidence Closure Conditions

A source may leave the current evidence queue only after its canonical identity, applicable version, owner/rights evidence, provenance chain, exact retained representation, professional-track evidence, and required clinical/technical/visual/accessibility/security reviews are independently documented. The decision must be attributable to the relevant qualified roles and must identify the exact artifact and locators reviewed. This report does not provide that decision.

## 7. Governance Impact and Allowed Next Action

The collection pass records the evidence that is already available and makes no claim that missing evidence has been acquired. It does not close any source gate, change the Master Source Registry, approve any source, or authorize a normalization phase. The allowed next action is to request and attach authoritative external identity, rights, provenance, and review evidence to the existing queue, preserving every retained artifact unchanged and separate by source family.

The following actions remain prohibited: content normalization, Content Record creation, Zod or Prisma work, SQL, migrations, imports, activation, publication, learner exposure, database changes, application changes, and any change to Source Registry approval states.

## 8. Final Control State

```text
APPROVED_SOURCES = NONE
NORMALIZATION = BLOCKED_PENDING_APPROVED_SOURCE
SOURCE_REGISTRY_APPROVAL_STATES = UNCHANGED
SEG_EXTERNAL_EVIDENCE_COLLECTION_BATCH_COMPLETE
```

## References

[1]: file:///home/ubuntu/seg-internship-output/SEG_EXTERNAL_EVIDENCE_ACQUISITION_TRACKER.md "SEG External Evidence Acquisition Tracker"
[2]: file:///home/ubuntu/seg-internship-output/SEG_TARGETED_EVIDENCE_CLOSURE_PLAN.md "SEG Targeted Evidence Closure Plan"
[3]: file:///home/ubuntu/seg-internship-output/SEG_MASTER_SOURCE_REGISTRY_STATUS.md "SEG Master Source Registry Status"
[4]: file:///home/ubuntu/seg-internship-output/SEG_EXTERNAL_EVIDENCE_ACQUISITION_FILE_REVIEW_REPORT.md "SEG External Evidence Acquisition File Review Report"
[5]: file:///home/ubuntu/seg-internship-output/SEG_HAMILTON_SOURCE_CLOSURE_DECISION.md "SEG Hamilton Source Closure Decision"
[6]: file:///home/ubuntu/seg-internship-output/SEG_JEM_NEXUS_EVIDENCE_CLOSURE_REPORT.md "SEG JEM Nexus Evidence Closure Report"

---

**SEG_EXTERNAL_EVIDENCE_COLLECTION_BATCH_COMPLETE**
